AMC Entertainment
GameStop
Zomedica
Churchill Capital Corp IV
Ideanomics
Nokia
QuantumScape
Ford Motor
Aphria
Biohaven Pharmaceutical Holding (BHVN) stock forecast for 2022
The forecast has been updated: June 18, 2021 9:28
Biohaven Pharmaceutical Holding stock price online today
Analyst Target Price
101.45Dividend Date
-Ex Dividend Date
-Last Split Factor
NoneLast Split Date
-Should you buy or sell Biohaven Pharmaceutical Holding stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Biohaven Pharmaceutical Holding stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $101.45 target price for Biohaven Pharmaceutical Holding stock stock.
Today 200 Day Moving Average is the support level (81.1849 $).
50 Day Moving Average is the support level (81.2289 $).
BHVN Forecast for 2022
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 106.05 | 100.91 | 114.91 | 12.18 % |
| Feb | 100.56 | 96.91 | 109.30 | 11.33 % |
| Mar | 105.43 | 99.40 | 112.50 | 11.65 % |
| Apr | 114.59 | 109.05 | 124.42 | 12.36 % |
| May | 111.82 | 103.70 | 114.52 | 9.45 % |
| Jun | 107.51 | 101.60 | 110.12 | 7.73 % |
| Jul | 107.63 | 101.12 | 110.95 | 8.86 % |
| Aug | 110.95 | 108.02 | 115.58 | 6.55 % |
| Sep | 108.26 | 99.09 | 115.41 | 14.14 % |
| Oct | 114.93 | 111.26 | 123.53 | 9.93 % |
| Nov | 123.27 | 116.09 | 130.19 | 10.83 % |
| Dec | 136.84 | 125.25 | 147.82 | 15.27 % |
The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Biohaven Pharmaceutical Holding stock.
Biohaven Pharmaceutical Holding overview
Biohaven Pharmaceutical Holding Address
215 Church Street, New Haven, CT, United States, 06510Market Capitalization
6 134 516 224 $EBITDA
-356 321 504PE Ratio
NonePEG Ratio
0Dividend Per Share
NoneDividend Yield
0EPS
-9.14Quarterly Earnings Growth YOY
0Quarterly Revenue Growth YOY
37.074Trailing PE
0Forward PE
0EV To Revenue
58.6827EV To EBITDA
052 Week High
106.56552 Week Low
57.6650 Day Moving Average
81.2289200 Day Moving Average
81.1849Shares Outstanding
65073900Shares Float
55023903Shares Short Prior Month
5358166Short Ratio
11.64Percent Insiders
12.371Percent Institutions
95.251Biohaven Pharmaceutical Holding stock forecast for this year
Biohaven Pharmaceutical Holding stock forecast for Jan 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 106.05. Positive monthly dynamics of the instrument is expected with 12.182% volatility is expected.
Pessimistic forecast: 100.91
Optimistic: 114.91
Biohaven Pharmaceutical Holding stock forecast for Feb 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 100.56. Negative monthly dynamics of the instrument is expected with 11.335% volatility is expected.
Pessimistic forecast: 96.91
Optimistic: 109.30
Biohaven Pharmaceutical Holding stock forecast for Mar 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 105.43. Positive monthly dynamics of the instrument is expected with 11.649% volatility is expected.
Pessimistic forecast: 99.40
Optimistic: 112.50
Biohaven Pharmaceutical Holding stock forecast for Apr 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 114.59. Positive monthly dynamics of the instrument is expected with 12.359% volatility is expected.
Pessimistic forecast: 109.05
Optimistic: 124.42
Biohaven Pharmaceutical Holding stock forecast for May 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 111.82. Negative monthly dynamics of the instrument is expected with 9.451% volatility is expected.
Pessimistic forecast: 103.70
Optimistic: 114.52
Biohaven Pharmaceutical Holding stock forecast for Jun 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 107.51. Negative monthly dynamics of the instrument is expected with 7.733% volatility is expected.
Pessimistic forecast: 101.60
Optimistic: 110.12
Biohaven Pharmaceutical Holding stock forecast for Jul 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 107.63. Positive monthly dynamics of the instrument is expected with 8.857% volatility is expected.
Pessimistic forecast: 101.12
Optimistic: 110.95
Biohaven Pharmaceutical Holding stock forecast for Aug 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 110.95. Positive monthly dynamics of the instrument is expected with 6.547% volatility is expected.
Pessimistic forecast: 108.02
Optimistic: 115.58
Biohaven Pharmaceutical Holding stock forecast for Sep 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 108.26. Negative monthly dynamics of the instrument is expected with 14.137% volatility is expected.
Pessimistic forecast: 99.09
Optimistic: 115.41
Biohaven Pharmaceutical Holding stock forecast for Oct 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 114.93. Positive monthly dynamics of the instrument is expected with 9.927% volatility is expected.
Pessimistic forecast: 111.26
Optimistic: 123.53
Biohaven Pharmaceutical Holding stock forecast for Nov 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 123.27. Positive monthly dynamics of the instrument is expected with 10.833% volatility is expected.
Pessimistic forecast: 116.09
Optimistic: 130.19
Biohaven Pharmaceutical Holding stock forecast for Dec 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 136.84. Positive monthly dynamics of the instrument is expected with 15.273% volatility is expected.
Pessimistic forecast: 125.25
Optimistic: 147.82